On the second day of the International Dental Show (IDS), it only got busier as both exhibitors and dental personnel filled up the conference halls, restaurants, and outer courtyard. Wandering the halls and speaking with multiple manufacturers, I?ve noticed that many companies share similar goals for what they want to achieve at the congress.
 
For one, IDS is an amazing platform to promote new products. For example, I?ve seen CAMLOG's new implant, as well as Maxillent's iRaise implant, which allows physicians to perform a sinus lift procedure at the same time as an implant placement. Live demonstrations are also a key way to sell to physicians, whether it was the fascinating abilities of dental lasers on egg shells and chicken cutlets, the efficiency and accuracy of dental CAD/CAM milling systems, the grandeur of 3D oral scanners, or the comprehensive videos of dental implant treatments.

Many of the leading competitors, however, had different goals. In this case, the primary focus was relationship management. Many of these competitors occupied multiple booths (in fact, DENTSPLY's booths covered over half a floor to become DENTSPLY Village!) in order to make sure that there were enough personnel and coverage to meet the questions of their current customers. In many cases, it was also the chance for these global companies to bring together teams from different regions of the world to meet one another and share their insights.

Finally, as I mentioned in the previous post, I?ve noticed an abundance of new companies that I had never heard of before. These companies are using the IDS as a chance to access the large Western European markets, find suitable distributors, and build awareness for their brands. While it is unlikely that all of the new companies will survive the competitiveness of the dental implant market, IDS has proven to be a platform for partnerships and expanding networks. At the same time, I think it is also perfect for those interested in competitive intelligence.  

What drives the therapy selection test market?

View Now